Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems. Mindray is globally headquartered in Shenzhen, China, with U.S. headquarters in Mahwah, New Jersey. Mindray also has another 12 international sales and service offices in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow, Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver.
For more information, please visit http://www.mindray.com .
Safe Harbor Statement
This announcement contains forward-looking statements. These statements
are made under the "safe harbor" provisions of the U.S. Private Securities
Litigation Reform Act of 1995. These forward-looking statements can be
identified by terminology such as "will," "expects," "anticipates,"
"future," "intends," "plans," "believes," "estimates," "confident" and
similar statements. Statements that are not historical facts, including
statements about Mindray's beliefs and expectations, are forward-looking
statements. Forward-looking statements involve inherent risks and
uncertainties. Information regarding these risks and uncertainties is
included in our public filings with the Securities and Exchange Commission.
All information provided in this press release is as of July 17, 2008, and
Mindray undertakes no duty to update such information, except as required
under applicable law.
For investor and media inquiries, please contact:
In the U.S:
Evan Smith,
FD
Tel: +1-212-850-5606
Email: evan.smith@fd.com
John Capodanno,
FD
Tel: +1-212-850-5705
Email: john.capodanno@fd.com
'/>"/>| SOURCE Mindray Medical International Limited Copyright©2008 PR Newswire. All rights reserved |